CLL cells are also characterized by high expression of Mcl-1 that antagonizes the pro-apoptotic effects of Bim [511, 512], and high Mcl-1 expression is associated with poor clinical outcome [513]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.